Article
Pharmacogenetics of P2Y 12 receptor inhibitors
2 Jan 2023
Abstract excerpt
Abstract Oral P2Y 12 inhibitors are commonly prescribed for cardiovascular disease and include clopidogrel, prasugrel, and ticagrelor. Each of these drugs has its strengths and weaknesses. Prasugrel and ticagrelor are more potent inhibitors of platelet aggregation and were shown to be superior to clopidogrel in preventing major adverse cardiovascular events after an acute coronary syndrome and percutaneous...
Topics
Join the communities discussing this publication.